Systems vaccinology for cancer vaccine development

References

• Gilboa E. The makings of a tumor rejection antigen. Immunity 1999;11:263-70
   PubMed Web of Science ®Google Scholar
• Pardoll DM. Inducing autoimmune disease to treat cancer. Proc Natl Acad Sci USA 1999;96:5340-2
   PubMed Web of Science ®Google Scholar
• Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 2012;12:298-306
   PubMed Web of Science ®Google Scholar
• Ideker T, Galitski T, Hood L. A new approach to decoding life: systems biology. Annu Rev Genomics Hum Genet 2001;2:343-72
   PubMed Web of Science ®Google Scholar
• Kitano H. Computational systems biology. Nature 2002;420:206-10
   PubMed Web of Science ®Google Scholar
• Nakaya HI, Pulendran B. Systems vaccinology: its promise and challenge for HIV vaccine development. Curr Opin HIV AIDS 2012;7:24-31
   PubMed Web of Science ®Google Scholar
• Pulendran B, Li S, Nakaya HI. Systems vaccinology. Immunity 2010;33:516-29
   PubMed Web of Science ®Google Scholar
• Buonaguro FM, Tornesello ML, Buonaguro L. Immune signatures and systems biology of vaccines. In: Marincola FM, Wang E, editors. Immunological signatures of rejection. Springer; 2011. 141-67
   Google Scholar
• Buonaguro L, Pulendran B. Immunogenomics and systems biology of vaccines. Immunol Rev 2011;239:197-208
   PubMed Web of Science ®Google Scholar
• Pulendran B. Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nat Rev Immunol 2009;9:741-7
   PubMed Web of Science ®Google Scholar
• Querec T, Bennouna S, Alkan S, et al. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med 2006;203:413-24
   PubMed Web of Science ®Google Scholar
• Querec TD, Akondy RS, Lee EK, et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 2009;10:116-25
   PubMed Web of Science ®Google Scholar
• Gaucher D, Therrien R, Kettaf N, et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 2008;205:3119-31
   PubMed Web of Science ®Google Scholar
• Aricò E, Wang E, Tornesello ML, et al. Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation. J Transl Med 2005;3:45
   PubMed Web of Science ®Google Scholar
• Buonaguro L, Tornesello ML, Tagliamonte M, et al. Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses. J Virol 2006;80:9134-43
   PubMed Web of Science ®Google Scholar
• Buonaguro L, Tornesello ML, Gallo RC, et al. Th2 Polarization in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus (HIV)-Infected Subjects, as Activated by HIV Virus-Like Particles. J Virol 2009;83:304-13
   PubMed Web of Science ®Google Scholar
• Buonaguro L, Petrizzo A, Tornesello M, et al. Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders. J Transl Med 2010;8:18
   PubMed Web of Science ®Google Scholar
• Buonaguro L, Wang E, Tornesello ML, et al. Systems biology applied to vaccine and immunotherapy development. BMC Syst Biol 2011;5:146
   PubMed Web of Science ®Google Scholar
• Monaco A, Marincola FM, Sabatino M, et al. Molecular immune signatures of HIV-1 vaccines in human PBMCs. FEBS Lett 2009;583:3004-8
   PubMed Web of Science ®Google Scholar
• Petrizzo A, Tornesello M, Buonaguro FM, Buonaguro L. Immunogenomics approaches for vaccine evaluation. J Immunotoxicol 2012;9:236-40
   PubMed Web of Science ®Google Scholar
• Poland GA, Ovsyannikova IG, Jacobson RM. Immunogenetics of seasonal influenza vaccine response. Vaccine 2008;26(Suppl 4):D35-40
   PubMed Web of Science ®Google Scholar
• Poland GA, Ovsyannikova IG, Kennedy RB, et al. Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections. OMICS 2011;15:625-36
   PubMed Web of Science ®Google Scholar
• Poland GA, Ovsyannikova IG, Jacobson RM. Personalized vaccines: the emerging field of vaccinomics. Expert Opin Biol Ther 2008;8:1659-67
   PubMed Web of Science ®Google Scholar
• Poland GA, Ovsyannikova IG, Jacobson RM, Smith DI. Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics. Clin Pharmacol Ther 2007;82:653-64
   PubMed Web of Science ®Google Scholar
• Petrizzo A, Tagliamonte M, Tornesello ML, et al. Prediction of individual immune responsiveness to a candidate vaccine by a systems vaccinology approach. J Transl Med 2014;12:11
   PubMed Web of Science ®Google Scholar
• Nakaya HI, Wrammert J, Lee EK, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 2011;12:786-95
   PubMed Web of Science ®Google Scholar
• Dabney AR. Classification of microarrays to nearest centroids. Bioinformatics 2005;21:4148-54
   PubMed Web of Science ®Google Scholar
• Lee EK. Large-scale optimization-based classification models in medicine and biology. Ann Biomed Eng 2007;35:1095-109
   PubMed Web of Science ®Google Scholar
• Richter JD, Sonenberg N. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature 2005;433:477-80
   PubMed Web of Science ®Google Scholar
• Ravindran R, Khan N, Nakaya HI, et al. Vaccine activation of the nutrient sensor GCN2 in dendritic cells enhances antigen presentation. Science 2014;343:313-17
   PubMed Web of Science ®Google Scholar
• Iwakoshi NN, Lee AH, Vallabhajosyula P, et al. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat Immunol 2003;4:321-9
   PubMed Web of Science ®Google Scholar
• Buonaguro L, Buonaguro FM, Tornesello ML, et al. High efficient production of Pr55gag Virus-like Particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A. Antiviral Res 2001;49:35-47
   PubMed Web of Science ®Google Scholar
• Visciano ML, Diomede L, Tagliamonte M, et al. Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins. Vaccine 2011;29:4903-12
   PubMed Web of Science ®Google Scholar
• Buonaguro L, Racioppi L, Tornesello ML, et al. Induction of neutralizing antibodies and CTLs in Balb/c mice immunized with Virus-like Particles presenting a gp120 molecule from a HIV-1 isolate of clade A (HIV-VLPAs). Antiviral Res 2002;54:189-201
   PubMed Web of Science ®Google Scholar
• Buonaguro L, Visciano ML, Tornesello ML, et al. Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation. J Virol 2005;79:7059-67
   PubMed Web of Science ®Google Scholar
• Buonaguro L, Devito C, Tornesello ML, et al. DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity. Vaccine 2007;25:5968-77
   PubMed Web of Science ®Google Scholar
• Buonaguro L, Tagliamonte M, Visciano ML, et al. Immunogenicity of HIV virus-like particles in rhesus macaques by intranasal administration. Clin Vaccine Immunol 2012;19:970-3
   PubMedGoogle Scholar
• Visciano ML, Tagliamonte M, Tornesello ML, et al. Effects of adjuvants on IgG subclasses elicited by virus-like particles. J Transl Med 2012;10:4
   PubMed Web of Science ®Google Scholar
• Buonaguro L, Monaco A, Arico E, et al. Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation. BMC Bioinformatics 2008;9(Suppl 2):S5
   PubMed Web of Science ®Google Scholar
• Magistrelli G, Jeannin P, Elson G, et al. Identification of three alternatively spliced variants of human CD28 mRNA. Biochem Biophys Res Commun 1999;259:34-7
   PubMed Web of Science ®Google Scholar
• Andres PG, Howland KC, Nirula A, et al. Distinct regions in the CD28 cytoplasmic domain are required for T helper type 2 differentiation. Nat Immunol 2004;5:435-42
   PubMed Web of Science ®Google Scholar
• Kozlow EJ, Wilson GL, Fox CH, Kehrl JH. Subtractive cDNA cloning of a novel member of the Ig gene superfamily expressed at high levels in activated B lymphocytes. Blood 1993;81:454-61
   PubMed Web of Science ®Google Scholar
• Beltinger CP, White PS, Maris JM, et al. Physical mapping and genomic structure of the human TNFR2 gene. Genomics 1996;35:94-100
   PubMed Web of Science ®Google Scholar
• Alderson MR, Smith CA, Tough TW, et al. Molecular and biological characterization of human 4-1BB and its ligand. Eur J Immunol 1994;24:2219-27
   PubMed Web of Science ®Google Scholar
• Stephan MT, Ponomarev V, Brentjens RJ, et al. T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection. Nat Med 2007;13:1440-9
   PubMed Web of Science ®Google Scholar
• Kawabe T, Naka T, Yoshida K, et al. The immune responses in. CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1994;1:167-78
   PubMed Web of Science ®Google Scholar
• Schonbeck U, Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 2001;58:4-43
   PubMed Web of Science ®Google Scholar
• Petrizzo A, Tornesello ML, Napolitano M, et al. Multiparametric analyses of human PBMCs loaded ex vivo with a candidate idiotype vaccine for HCV-related lymphoproliferative disorders. PLoS One 2012;7:e44870
   Web of Science ®Google Scholar
• Muruve DA, Petrilli V, Zaiss AK, et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 2008;452:103-7
   PubMed Web of Science ®Google Scholar
• Petrilli V, Dostert C, Muruve DA, Tschopp J. The inflammasome: a danger sensing complex triggering innate immunity. Curr Opin Immunol 2007;19:615-22
   PubMed Web of Science ®Google Scholar
• Li H, Willingham SB, Ting JP, Re F. Cutting edge: inflammasome activation by alum and alum’s adjuvant effect are mediated by NLRP3. J Immunol 2008;181:17-21
   PubMed Web of Science ®Google Scholar
• Yasue T, Nishizumi H, Aizawa S, et al. A critical role of Lyn and Fyn for B cell responses to CD38 ligation and interleukin 5. Proc Natl Acad Sci U S A 1997;94:10307-12
   PubMed Web of Science ®Google Scholar
• Li S, Rouphael N, Duraisingham S, et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol 2014;15:195-204
   PubMed Web of Science ®Google Scholar
• Dhiman N, Ovsyannikova IG, Vierkant RA, et al. Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results. Vaccine 2008;26:1731-6
   PubMed Web of Science ®Google Scholar
• Ovsyannikova IG, Dhiman N, Haralambieva IH, et al. Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes. Hum Genet 2010;127:207-21
   PubMed Web of Science ®Google Scholar
• Banus S, Bottema RW, Siezen CL, et al. Toll-like receptor 4 polymorphism associated with the response to whole-cell pertussis vaccination in children from the KOALA study. Clin Vaccine Immunol 2007;14:1377-80
   PubMedGoogle Scholar
• Kimman TG, Banus S, Reijmerink N, et al. Association of interacting genes in the toll-like receptor signaling pathway and the antibody response to pertussis vaccination. PLoS One 2008;3:e3665
   Web of Science ®Google Scholar
• Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol 2004;22:329-60
   PubMed Web of Science ®Google Scholar
• Dunn GP, Bruce AT, Ikeda H, et al. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002;3:991-8
   PubMed Web of Science ®Google Scholar
• Nambiar PR, Gupta RR, Misra V. An “Omics” based survey of human colon cancer. Mutat Res 2010;693:3-18
   PubMed Web of Science ®Google Scholar
• De Giorgi V, Buonaguro L, Worschech A, et al. Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis. PLoS One 2013;8:e56153
   Web of Science ®Google Scholar
• Habermann JK, Paulsen U, Roblick UJ, et al. Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis. Genes Chromosomes Cancer 2007;46:10-26
   PubMed Web of Science ®Google Scholar
• Habermann JK, Bundgen NK, Gemoll T, et al. Genomic instability influences the transcriptome and proteome in endometrial cancer subtypes. Mol Cancer 2011;10:132
   PubMed Web of Science ®Google Scholar
• Wood LD, Parsons DW, Jones S, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007;318:1108-13
   PubMed Web of Science ®Google Scholar
• Pleasance ED, Cheetham RK, Stephens PJ, et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 2010;463:191-6
   PubMed Web of Science ®Google Scholar
• Castle JC, Kreiter S, Diekmann J, et al. Exploiting the mutanome for tumor vaccination. Cancer Res 2012;72:1081-91
   PubMed Web of Science ®Google Scholar
• Rammensee H, Bachmann J, Emmerich NP, et al. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999;50:213-19
   PubMed Web of Science ®Google Scholar
• Singh H, Raghava GP. ProPred: prediction of HLA-DR binding sites. Bioinformatics 2001;17:1236-7
   PubMed Web of Science ®Google Scholar
• Reche PA, Glutting JP, Reinherz EL. Prediction of MHC class I binding peptides using profile motifs. Hum Immunol 2002;63:701-9
   PubMed Web of Science ®Google Scholar
• Guan P, Hattotuwagama CK, Doytchinova IA, Flower DR. MHCPred 2.0: an updated quantitative T-cell epitope prediction server. Appl Bioinformatics 2006;5:55-61
   PubMedGoogle Scholar
• Bachinsky MM, Guillen DE, Patel SR, et al. Mapping and binding analysis of peptides derived from the tumor-associated antigen survivin for eight HLA alleles. Cancer Immun 2005;5:6
   Google Scholar
• Patronov A, Doytchinova I. T-cell epitope vaccine design by immunoinformatics. Open Biol 2013;3:120139
   PubMed Web of Science ®Google Scholar
• Lu J, Celis E. Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes. Cancer Res 2000;60:5223-7
   PubMed Web of Science ®Google Scholar
• Nussbaum AK, Kuttler C, Tenzer S, Schild H. Using the World Wide Web for predicting CTL epitopes. Curr Opin Immunol 2003;15:69-74
   PubMed Web of Science ®Google Scholar
• Andersen MH, Tan L, Sondergaard I, et al. Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules. Tissue Antigens 2000;55:519-31
   PubMedGoogle Scholar
• Kessler JH, Melief CJ. Identification of T-cell epitopes for cancer immunotherapy. Leukemia 2007;21:1859-74
   PubMedGoogle Scholar
• Singh-Jasuja H, Emmerich NP, Rammensee HG. The Tubingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy. Cancer Immunol Immunother 2004;53:187-95
   PubMed Web of Science ®Google Scholar
• Mester G, Hoffmann V, Stevanovic S. Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands. Cell Mol Life Sci 2011;68:1521-32
   PubMed Web of Science ®Google Scholar
• Dutoit V, Herold-Mende C, Hilf N, et al. Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy. Brain 2012;135:1042-54
   PubMed Web of Science ®Google Scholar
• Sahin U, Tureci O, Schmitt H, et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 1995;92:11810-13
   PubMed Web of Science ®Google Scholar
• Gnjatic S, Nishikawa H, Jungbluth AA, et al. NY-ESO-1: review of an immunogenic tumor antigen. Adv Cancer Res 2006;95:1-30
   PubMed Web of Science ®Google Scholar
• Hardouin J, Lasserre JP, Sylvius L, et al. Cancer immunomics: from serological proteome analysis to multiple affinity protein profiling. Ann N Y Acad Sci 2007;1107:223-30
   PubMed Web of Science ®Google Scholar
• Klade CS, Voss T, Krystek E, et al. Identification of tumor antigens in renal cell carcinoma by serological proteome analysis. Proteomics 2001;1:890-8
   PubMed Web of Science ®Google Scholar
• Anderson KS, Ramachandran N, Wong J, et al. Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer. J Proteome Res 2008;7:1490-9
   PubMed Web of Science ®Google Scholar
• Zhong L, Hidalgo GE, Stromberg AJ, et al. Using protein microarray as a diagnostic assay for non-small cell lung cancer. Am J Respir Crit Care Med 2005;172:1308-14
   PubMed Web of Science ®Google Scholar
• Wang X, Yu J, Sreekumar A, et al. Autoantibody signatures in prostate cancer. N Engl J Med 2005;353:1224-35
   PubMed Web of Science ®Google Scholar
• Gunawardana CG, Diamandis EP. High throughput proteomic strategies for identifying tumour-associated antigens. Cancer Lett 2007;249:110-19
   PubMed Web of Science ®Google Scholar
• Blixt O, Clo E, Nudelman AS, et al. A high-throughput O-glycopeptide discovery platform for seromic profiling. J Proteome Res 2010;9:5250-61
   PubMed Web of Science ®Google Scholar
• Disis ML. Immunologic biomarkers as correlates of clinical response to cancer immunotherapy. Cancer Immunol Immunother 2011;60:433-42
   PubMed Web of Science ®Google Scholar
• Inderberg-Suso EM, Trachsel S, Lislerud K, et al. Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001. Oncoimmunology 2012;1:670-86
   PubMed Web of Science ®Google Scholar
• Hardwick N, Chain B. Epitope spreading contributes to effective immunotherapy in metastatic melanoma patients. Immunotherapy 2011;3:731-3
   Google Scholar
• Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 2005;5:263-74
   PubMed Web of Science ®Google Scholar
• Farsaci B, Higgins JP, Hodge JW. Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy. Int J Cancer 2012;130:1948-59
   PubMed Web of Science ®Google Scholar
• Ko JS, Zea AH, Rini BI, et al. Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients. Clin Cancer Res 2009;15:2148-57
   PubMed Web of Science ®Google Scholar
• Nefedova Y, Nagaraj S, Rosenbauer A, et al. Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway. Cancer Res 2005;65:9525-35
   PubMed Web of Science ®Google Scholar
• Soen Y, Chen DS, Kraft DL, et al. Detection and characterization of cellular immune responses using peptide-MHC microarrays. PLoS Biol 2003;1:E65
   PubMed Web of Science ®Google Scholar
• Yue C, Oelke M, Paulaitis ME, Schneck JP. Novel cellular microarray assay for profiling T-cell peptide antigen specificities. J Proteome Res 2010;9:5629-37
   PubMed Web of Science ®Google Scholar
• Rice JM, Stern LJ, Guignon EF, et al. Antigen-specific T cell phenotyping microarrays using grating coupled surface plasmon resonance imaging and surface plasmon coupled emission. Biosens Bioelectron 2012;31:264-9
   PubMed Web of Science ®Google Scholar